ERBB2 and cancer: Numerous APLs have been designed for cancer epitopes and include, amongst others, MUC1-HLA-A2 (14), HER1-HLA-A2 (15), HER2-HLA-A2 (16), HER2-HLA-A24 (17), MelanA-HLA-A2 (18), gp100-HLA-A2 [epitopes 154, 209, and 280 (19)], TRP2-HLA-A2 (20), PSA-HLA-A2 (21), and NY-ESO1-HLA-A2 (22).